Peter Brieger Millipore Corp. MIL-N PAST TOP PICK Jan 27, 2011

Healthcare serving markets in the far east. 45% is providing equipment and services to biosciences exploring new drugs, therapies, etc. Other part is bioprocess, using molecular structure as opposed to chemical compounds.

Life science business - biosciences (helps with discovery of new drugs) & bioprocess (testing equipment and quality assistance). Modern drugs require much higher quality standards and testing procedures. As the need for drugs increases this stock will increase exponentially.

Bought for basic business. Thought it would be a 3-5 year hold but it shot up in 6 days. Two companies made bids to buy it.